Document Detail


Life quality assessment among patients with atopic eczema.
MedLine Citation:
PMID:  16536816     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Quantification of quality of life (QoL) related to disease severity is important in patients with atopic eczema (AE), because the assessment provides additional information to the traditional objective clinical scoring systems. OBJECTIVES: To measure health-related QoL (HRQoL) in patients with AE; to analyse discriminant, divergent and convergent validity by examining the association between various QoL methods; and to examine the association between disease severity assessed by an objective Severity Scoring of Atopic Dermatitis (SCORAD) and QoL. METHODS: HRQoL was assessed at two visits at a 6-monthly interval in 101 patients with AE and 30 controls with one dermatology-specific questionnaire [Dermatology Life Quality Index (DLQI) or Children's DLQI (CDLQI)], one generic instrument (SF-36) and three visual analogue scales (VASs) of severity and pruritus. Objective SCORAD was used to measure disease severity. RESULTS: Patients with AE had significantly lower QoL than healthy controls and the general population. DLQI /CDLQI, pruritus, and patient and investigator overall assessment of eczema severity were significantly (P < 0.0001) and positively correlated with SCORAD, while the generic questionnaire showed only poor correlation. A gender difference was found for the mental component score of SF-36 (P = 0.019). CONCLUSIONS: AE has an impact on HRQoL. Patients' mental health, social functioning and role emotional functioning seem to be more affected than physical functioning. A simple VAS score of patients' assessment of disease severity showed the highest and most significant correlations with most of the HRQoL methods used. There is evidence to support the ability of patients with AE to make an accurate determination of their disease severity and QoL.
Authors:
E A Holm; H C Wulf; H Stegmann; G B E Jemec
Related Documents :
17851016 - Determinants and patient-reported long-term outcomes of physician empathy in oncology: ...
18647806 - Quality of life in acromegalic patients during long-term somatostatin analog treatment ...
19172276 - Relationship between spinal mobility measures and quality of life in patients with anky...
16036506 - Development and validation of the patient assessment of constipation quality of life qu...
24738146 - Clinical evidence on hemodiafiltration: a systematic review and a meta-analysis.
21398266 - Do symptoms matter when considering patients for phase i clinical trials? a pilot study...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Validation Studies    
Journal Detail:
Title:  The British journal of dermatology     Volume:  154     ISSN:  0007-0963     ISO Abbreviation:  Br. J. Dermatol.     Publication Date:  2006 Apr 
Date Detail:
Created Date:  2006-03-15     Completed Date:  2006-08-09     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0004041     Medline TA:  Br J Dermatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  719-25     Citation Subset:  IM    
Affiliation:
Division of Dermatology, Roskilde Hospital, University of Copenhagen, Koegevej 7-13, DK 4000 Roskilde, Denmark. rselho@ra.dk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Child
Child, Preschool
Dermatitis, Atopic / physiopathology,  psychology*,  rehabilitation
Female
Health Status Indicators*
Humans
Male
Middle Aged
Psychometrics
Quality of Life*
Severity of Illness Index

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  In vitro and in vivo comparison of two different light sources for topical photodynamic therapy.
Next Document:  Etanercept: effective in the management of hidradenitis suppurativa.